Vandana Singh
·
January 2, 2025
Benzinga
Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise capacity improvements.
read more
January 10, 2025
January 7, 2025
January 8, 2025